The SELECT trial enrolled over 17,000 participants with established cardiovascular disease and obesity (without diabetes) and followed them for a median of approximately 40 months
TSA regulations explicitly allow medications, syringes, and cooling supplies, so officers are simply verifying compliance, not looking for reasons to confiscate items
This study was limited in scope: Conducted on 24 rats, not humans Administered a single dose Designed only to demonstrate that some absorption is possible Importantly, the study itself includes this disclaimer: This proof-of-concept study is not intended to provide guidance on the sublingual dosing of semaglutide in humans, or dosing conversion from other forms to sublingual administration. This means the only research behind these products cannot confirm whether they work in humans or provide guidance on appropriate dosing
The December 2025 trial also showed improvements in joint pain
Politics Meets Metabolism Trumps populist framingbringing obesity care to every American seniortransforms GLP-1s into a political symbol as much as a public-health tool
Compounding also allows for customization of medications to meet your needs